317 related articles for article (PubMed ID: 8542026)
1. Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.
Telen MJ
Transfus Clin Biol; 1995; 2(4):277-90. PubMed ID: 8542026
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.
Lublin DM; Mallinson G; Poole J; Reid ME; Thompson ES; Ferdman BR; Telen MJ; Anstee DJ; Tanner MJ
Blood; 1994 Aug; 84(4):1276-82. PubMed ID: 7519480
[TBL] [Abstract][Full Text] [Related]
4. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
Edberg JC; Salmon JE; Whitlow M; Kimberly RP
J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
[TBL] [Abstract][Full Text] [Related]
5. Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.
Lublin DM; Thompson ES; Green AM; Levene C; Telen MJ
J Clin Invest; 1991 Jun; 87(6):1945-52. PubMed ID: 1710232
[TBL] [Abstract][Full Text] [Related]
6. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology.
Telen MJ; Rao N; Udani M; Thompson ES; Kaufman RM; Lublin DM
Blood; 1994 Nov; 84(9):3205-11. PubMed ID: 7524769
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.
Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ
Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516
[TBL] [Abstract][Full Text] [Related]
8. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.
Nishimura J; Murakami Y; Kinoshita T
Am J Hematol; 1999 Nov; 62(3):175-82. PubMed ID: 10539884
[TBL] [Abstract][Full Text] [Related]
9. [Paroxysmal nocturnal hemoglobinuria].
Hernández-Campo PM; Almeida J; Orfao A
Med Clin (Barc); 2008 Nov; 131(16):617-30. PubMed ID: 19080854
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of paroxysmal nocturnal hemoglobinuria.
Parker CJ
Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood harvest of unaffected CD34+ CD38- hematopoietic precursors in paroxysmal nocturnal hemoglobinuria.
Prince GM; Nguyen M; Lazarus HM; Brodsky RA; Terstappen LW; Medof ME
Blood; 1995 Nov; 86(9):3381-6. PubMed ID: 7579441
[TBL] [Abstract][Full Text] [Related]
12. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
[TBL] [Abstract][Full Text] [Related]
13. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
[TBL] [Abstract][Full Text] [Related]
14. Expression of recombinant transmembrane CD59 in paroxysmal nocturnal hemoglobinuria B cells confers resistance to human complement.
Rother RP; Rollins SA; Mennone J; Chodera A; Fidel SA; Bessler M; Hillmen P; Squinto SP
Blood; 1994 Oct; 84(8):2604-11. PubMed ID: 7522635
[TBL] [Abstract][Full Text] [Related]
15. Decay-accelerating factor (CD55) deficiency phenotypes in Japanese.
Daniels GL; Green CA; Mallinson G; Okubo Y; Hori Y; Kataoka A; Kaihara M
Transfus Med; 1998 Jun; 8(2):141-7. PubMed ID: 9675792
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol-glycan linked proteins of the erythrocyte membrane.
Telen MJ; Rosse WF
Baillieres Clin Haematol; 1991 Dec; 4(4):849-68. PubMed ID: 1724205
[TBL] [Abstract][Full Text] [Related]
17. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
18. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
Hillmen P; Hows JM; Luzzatto L
Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
[TBL] [Abstract][Full Text] [Related]
19. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of glycosyl-phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay-accelerating factor (DAF) and CD16 on PNH neutrophils.
Kawakami Z; Ninomiya H; Tomiyama J; Abe T
Br J Haematol; 1990 Apr; 74(4):508-13. PubMed ID: 1693286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
